Patent details

EP2539439 Title: MODULATION OF ANGIOGENESIS

Basic Information

Publication number:
EP2539439
PCT Application Number:
US2011025846
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117479584
PCT Publication Number:
WO2011106365
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODULATION OF ANGIOGENESIS
French Title of Invention:
MODULATION DE L'ANGIOGENÈSE
German Title of Invention:
ANGIOGENESE-MODULATION
SPC Number:

Dates

Filing date:
23/02/2011
Grant date:
17/10/2018
EP Publication Date:
02/01/2013
PCT Publication Date:
01/09/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/10/2018
EP B1 Publication Date:
17/10/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/02/2019
Expiration date:
23/02/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/10/2018
 
 

Name:
ABT Holding Company
Address:
3201 Carnegie Avenue, Cleveland, OH 44115, United States (US)

Inventor

1

Name:
LEHMAN, Nicholas, A.
Address:
United States (US)

2

Name:
WODA, Juliana, Megan
Address:
United States (US)

3

Name:
TING, Anthony, E.
Address:
United States (US)

Priority

Priority Number:
308103 P
Priority Date:
25/02/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/19; A61K 38/20; A61P 9/00; G01N 33/50; C12N 5/074; A61K 35/545;

Publication

European Patent Bulletin

Issue number:
201842
Publication date:
17/10/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages